The volume of audio files that potentially contain valuable data on adverse events (AEs) has exploded, outpacing the pace pharmacovigilance (PV) operations originally anticipated in the COVID era. Healthcare company call centers, which in some instances saw up to 75% of adverse drug reaction (ADR) notifications reported through this channel, are challenged to handle this drastic increase in source data that requires tedious review for potential safety events or risks contained in audio interactions and transcriptions. As the increase in source volumes surpasses normal hiring capabilities, pharmaceutical companies face a growing challenge to ensure compliance with AE reporting regulations.
The need for a technology solutionAnyone contacting a healthcare provider (HCP), healthcare regulator or a medical commercial call center could disclose potential adverse events (PA…